Drug RecallsJanus Kinase (JAK) inhibitors: Drug Safety Communication – FDA Requires Warnings about Increased Risk of Serious Heart-related Events, Cancer, Blood Clots, and Death Posted on by Editor Date: 09/01/2021 Product type: Drugs US-FDA Link: https://www.fda.gov/safety/medical-product-safety-information/janus-kinase-jak-inhibitors-drug-safety-communication-fda-requires-warnings-about-increased-risk Magellan Diagnostics, Inc. Expands Voluntary Recall of LeadCare® Test Kits Mammography Problems at Madison Avenue Radiology Center 190th Broadway in New York, New York: FDA Safety Communication
